These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 12730559)

  • 1. Oral anticoagulation in patients after cerebral ischemia of arterial origin and risk of intracranial hemorrhage.
    ESPRIT
    Stroke; 2003 Jun; 34(6):e45-6. PubMed ID: 12730559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized trial of anticoagulants versus aspirin after cerebral ischemia of presumed arterial origin. The Stroke Prevention in Reversible Ischemia Trial (SPIRIT) Study Group.
    Ann Neurol; 1997 Dec; 42(6):857-65. PubMed ID: 9403477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary stroke prevention with antithrombotic drugs.
    De Schryver EL; Algra A
    Curr Vasc Pharmacol; 2010 Jan; 8(1):129-33. PubMed ID: 19485938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medium intensity oral anticoagulants versus aspirin after cerebral ischaemia of arterial origin (ESPRIT): a randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet Neurol; 2007 Feb; 6(2):115-24. PubMed ID: 17239798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Prevention of vascular complications following cerebral ischemia of arterial origin; the ESPRIT trial: mild anticoagulant therapy, combination treatment with acetylsalicylic acid plus dipyridamole or treatment with acetylsalicylic acid alone?].
    Gorter JW; De Schryver EL; Algra A
    Ned Tijdschr Geneeskd; 1998 Feb; 142(6):316-8. PubMed ID: 9562733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: impact of quality of anticoagulation control.
    Ho CW; Ho MH; Chan PH; Hai JJ; Cheung E; Yeung CY; Lau KK; Chan KH; Lau CP; Lip GY; Leung GK; Tse HF; Siu CW
    Stroke; 2015 Jan; 46(1):23-30. PubMed ID: 25406148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Secondary prevention after ischemic cerebral infarct. The ESPRIT Study: low dose anticoagulation, combined therapy with acetylsalicylic acid/dipyridamole or monotherapy with acetylsalicylic acid?].
    Gorter JW; De Schryver EL; Algra A
    Nervenarzt; 1999 Apr; 70(4):368-70. PubMed ID: 10355002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging therapies: ESPRIT.
    Moussouttas M
    Stroke; 2007 Apr; 38(4):1142. PubMed ID: 17303765
    [No Abstract]   [Full Text] [Related]  

  • 9. New developments in secondary stroke prevention: impact of the European/Australasian Stroke Prevention in Reversible Ischemia Trial (ESPRIT) on clinical management.
    Lutsep HL
    J Stroke Cerebrovasc Dis; 2007; 16(6):263-7. PubMed ID: 18035244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial.
    ; Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A
    Lancet; 2006 May; 367(9523):1665-73. PubMed ID: 16714187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determinants of intracranial hemorrhage incidence in patients on oral anticoagulation followed at the Lahey clinic.
    Mantha S; Pianka AM; Tsapatsaris N
    J Thromb Thrombolysis; 2011 Oct; 32(3):334-42. PubMed ID: 21674132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Major bleeding during anticoagulation after cerebral ischemia: patterns and risk factors. Stroke Prevention In Reversible Ischemia Trial (SPIRIT). European Atrial Fibrillation Trial (EAFT) study groups.
    Gorter JW
    Neurology; 1999 Oct; 53(6):1319-27. PubMed ID: 10522891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ESPRIT: is aspirin plus dipyridamole superior to aspirin alone in TIA or minor stroke patients?
    Rouhl RP; Lodder J
    Expert Rev Neurother; 2008 Nov; 8(11):1661-5. PubMed ID: 18986236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation.
    Hylek EM; Go AS; Chang Y; Jensvold NG; Henault LE; Selby JV; Singer DE
    N Engl J Med; 2003 Sep; 349(11):1019-26. PubMed ID: 12968085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral anticoagulant treatment with and without aspirin.
    Altman R; Rouvier J; Gurfinkel E
    Thromb Haemost; 1995 Jul; 74(1):506-10. PubMed ID: 8578514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of ESPRIT: an international randomized trial for secondary prevention after non-disabling cerebral ischaemia of arterial origin. European/Australian Stroke Prevention in Reversible Ischaemia Trial (ESPRIT) group.
    De Schryver EL
    Cerebrovasc Dis; 2000; 10(2):147-50. PubMed ID: 10686454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term PT-INR levels and the clinical events in the patients with non-valvular atrial fibrillation: a special reference to low-intensity warfarin therapy.
    Takarada K; Sato M; Goto M; Saito A; Ikeda Y; Fujita S; Fuse K; Takahashi M; Oguro T; Matsushita H; Kitazawa H; Okabe M; Abe H; Toba K; Yamashina A; Aizawa Y
    J Cardiol; 2014 Aug; 64(2):127-32. PubMed ID: 24440439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [No role for oral anticoagulants (target INR: 2.0-3.0) after transient ischaemic attack or cerebral infarction of arterial origin; the 'European/Australasian stroke prevention in reversible ischaemia trial' (ESPRIT)].
    De Schryver EL; Halkes PH
    Ned Tijdschr Geneeskd; 2008 Feb; 152(8):445-53. PubMed ID: 18361194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety of intravenous thrombolysis for acute ischemic stroke in patients receiving antiplatelet therapy at stroke onset.
    Diedler J; Ahmed N; Sykora M; Uyttenboogaart M; Overgaard K; Luijckx GJ; Soinne L; Ford GA; Lees KR; Wahlgren N; Ringleb P
    Stroke; 2010 Feb; 41(2):288-94. PubMed ID: 20056933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk indicators for development of headache during dipyridamole treatment after cerebral ischaemia of arterial origin.
    Halkes PH; van Gijn J; Kappelle LJ; Koudstaal PJ; Algra A;
    J Neurol Neurosurg Psychiatry; 2009 Apr; 80(4):437-9. PubMed ID: 19289481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.